Journal Information
Original article
Prognostic value of anti-IFI16 autoantibodies in pulmonary arterial hypertension and mortality in patients with systemic sclerosis
Valor pronóstico de los autoanticuerpos anti-IFI16 en la hipertensión arterial pulmonar y en la mortalidad en los pacientes con esclerodermia sistémica
Janire Perurena-Prietoa,b,c, Eduardo L. Callejas-Moragad, María T. Sanz-Martíneza, Roger Colobrana,b,c,e,
, Alfredo Guillén-Del-Castillof,1,
, Carmen P. Simeón-Aznarf,1
Corresponding author
Corresponding author
a Immunology Division, Vall d’Hebron University Hospital (HUVH), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
b Translational Immunology Group, Vall d’Hebron Research Institute (VHIR), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
c Department of Cell Biology, Physiology and Immunology, Autonomous University of Barcelona (UAB), Bellaterra, Spain
d Internal Medicine Department, Hospital Público de Monforte, Lugo, Spain
e Department of Clinical and Molecular Genetics, Vall d’Hebron University Hospital (HUVH), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
f Systemic Autoimmune Diseases Unit, Internal Medicine Department, Vall d’Hebron University Hospital (HUVH), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain